# A Study to Evaluate the Safety, Tolerability and Effects of MEDI-563 in Adults With Asthma

> **NCT00659659** · PHASE1 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 27 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** MEDI-563
- **DRUG:** MEDI-563
- **OTHER:** Placebo Comp.
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00659659
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2011-01
- **Final completion:** 2011-03
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2012-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00659659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00659659, "A Study to Evaluate the Safety, Tolerability and Effects of MEDI-563 in Adults With Asthma". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00659659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*